Milken Institute School of Public Health site logo

Milken Institute School of Public Health

 

Fouzia Farooq

No Profile Picture Found

Fouzia Farooq

Assistant Research Professor

Full-time Faculty

School: Milken Institute School of Public Health

Department: Global Health

Contact:

Email: Fouzia Farooq
Milken Institute School of Public Health 950 New Hampshire Avenue, NW Washington DC 20052

Dr. Farooq is an assistant professor in the Department of Global Health at GW. She is a perinatal epidemiologist and works on a large study called The Pregnancy Risk and Infant Surveillance and Measurement Alliance (PRISMA) Maternal and Newborn Health (MNH). PRISMA is a population based, open-cohort study that seeks to evaluate pregnancy risk factors and their associations with adverse pregnancy outcomes, including maternal morbidity and mortality. This study is spread across six sites across Pakistan, India, Ghana, Kenya and Zambia. 
Dr. Farooq received her PhD from University of Pittsburgh in Epidemiology 2022 and completed her postdoctoral fellowship at the Milken Institute of Public Health, Department of Global Health, The George Washington University in 2023. She has also worked on malaria and ebola vaccine development and studying immune correlates of protection at the DoD.

  1. Ph.D. 2022, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, Epidemiology

  2. MPH, 2015, George Mason University, College of Health and Human Services, Fairfax, Epidemiology

  3. B.S. 2007, George Mason University, Fairfax, Biology

PUBH 6047 Systematic Review to Synthesize Evidence in Public Health Practice
 
My research focuses on improving maternal and child health in low and middle income countries. I work in Pakistan, India, Kenya, Zambia, and Ghana.
 
  1. Naz, S, Jaffar, A, Yazdani, N, Kashif, M, Hussain, Z, Khan, U, Farooq, F, Nisar, MI, Jehan, F, Smith ER, Hoodbhoy Z. Cohort profile: the Pregnancy Risk Infant Surveillance and Measurement Alliance (PRISMA) - Pakistan. BMJ Open. 2023 Dec 10;13(12):e078222. doi: 10.1136/bmjopen-2023-078222
  2. Kazma J, Ebner E, Slota J, Berger JS, Farooq F, Smith ER, Ahmadzia HK, The Correlation of Non-invasive Hemoglobin (SpHb) Testing and Lab Hemoglobin in Surgical Patients: A Systematic Review and Meta-analysis.
    Perfusion. 2024. doi: 10.1177/02676591241226465.
  3. Farooq F, Smith ER, Pan Q. et al. Comparison of Masimo Total Hemoglobin SpHb® continuous non-invasive hemoglobin monitoring device with laboratory complete blood count measurement using venous sample: Protocol for an observational substudy of the Pregnancy Risk and Infant Surveillance and Measurement Alliance Maternal and Newborn Health (PRISMA MNH) study. Gates Open Research. 2023. doi: 10.12688/gatesopenres.14499.1.
  4. Farooq F, Oakley E, Kerchner D. et al. Risk of Adverse Maternal and Fetal Outcomes Associated with COVID-19 Variants of Concern: A Sequential Prospective Meta-Analysis. Preprint medRxiv 2023.04.03.23287260 (2023). doi:10.1101/2023.04.03.23287260.
  5. Gudipally M*, Farooq F*, Basany K, Haggerty CL, Tang G, Kusneniwar GN, Jammy GR, Bunker CH, Reddy PS. Impact of pre-pregnancy body mass index on adverse pregnancy outcomes: Analysis from the Longitudinal Indian Family hEalth cohort study. AJOG Global Reports. 2022. doi: 10.1016/j.xagr.2022.100134.
    *Joint first authorship
  6. Smith ER, Oakley E, Grandner GW, Ferguson K, Farooq F, Afshar Y, Ahlberg M, Ahmadzia H, Akelo V, Aldrovandi G, Tippett Barr BA, Bevilacqua E, Brandt JS, Broutet N, Fernandez Buhigas I, Carrillo J, Clifton R, Conry J, Cosmi E, Crispi F, Crovetto F, Delgado-Lopez C, Divakar H, Driscoll AJ, Favre G, Flaherman VJ, Gale C, Gil MM, Gottlieb SL, Gratacos E, Hernandez O, Jones S, Kalafat E, Khagayi S, Knight M, Kotloff K, Lanzone A, Le Doare K, Lees C, Litman E, Lokken EM, Laurita Longo V, Madhi SA, Magee LA, Martinez-Portilla RJ, McClure EM, Metz TD, Miller ES, Money D, Moungmaithong S, Mullins E, Nachega JB, Nunes MC, Onyango D, Panchaud A, Poon LC, Raiten D, Regan L, Rukundo G, Sahota D, Sakowicz A, Sanin-Blair J, Soderling J, Stephansson O, Temmerman M, Thorson A, Tolosa JE, Townson J, Valencia-Prado M, Visentin S, von Dadelszen P, Adams Waldorf K, Whitehead C, Yassa M, Tielsch JM, Perinatal CPMASC, and Perinatal CPMASC. Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis. BMJ Glob Health. 2023;8(1). doi: 10.1136/bmjgh-2022-009495. PubMed PMID: 36646475; PMCID: PMC9895919.
  7. Smith ER, Oakley E, Grandner GW, Rukundo G, Farooq F, Ferguson K, Baumann S, Waldorf KA, Afshar Y, Ahlberg M, Ahmadzia H, Akelo V, Aldrovandi G, Bevilacqua E, Bracero N, Brandt JS, Broutet N, Carrillo J, Conry J, Cosmi E, Crispi F, Crovetto F, Gil MDM, Delgado-Lopez C, Divakar H, Driscoll AJ, Favre G, Buhigas IF, Flaherman V, Gale C, Godwin CL, Gottlieb S, Gratacos E, He S, Hernandez O, Jones S, Joshi S, Kalafat E, Khagayi S, Knight M, Kotloff K, Lanzone A, Longo VL, Le Doare K, Lees C, Litman E, Lokken EM, Madhi SA, Magee LA, Martinez-Portilla RJ, Metz TD, Miller ES, Money D, Moungmaithong S, Mullins E, Nachega JB, Nunes MC, Onyango D, Panchaud A, Poon LC, Raiten D, Regan L, Sahota D, Sakowicz A, Sanin-Blair J, Stephansson O, Temmerman M, Thorson A, Thwin SS, Tippett Barr BA, Tolosa JE, Tug N, Valencia-Prado M, Visentin S, von Dadelszen P, Whitehead C, Wood M, Yang H, Zavala R, Tielsch JM. Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: A sequential, prospective meta-analysis. Am J Obstet Gynecol. 2022. Epub 20220823. doi: 10.1016/j.ajog.2022.08.038. PubMed PMID: 36027953; PMCID: PMC9398561.
  8. Broniatowski DA, Kerchner D, Farooq F, Huang X, Jamison, AM, Dredze M, Quinn SC, Ayers JW. Twitter and Facebook posts about COVID-19 are less likely to spread misinformation compared to other health topics. PLoS ONE. 2022;17(1): e0261768.  https://doi.org/10.1371/journal.pone.0261768
  9. Robertson JM, Basany K, Farooq F, Tan X, Tang G, Bunker CH, Reddy PS, Haggerty CL. Consanguineous Marriage and Early Pregnancy Loss in Rural to Peri-Urban India. The Journal of Obstetrics and Gynecology of India. 2021. doi: 10.1007/s13224-021-01498-7.
  10. Haggerty CL, Ness RB, Totten PA, Farooq F, Tang G, Ko D, Hou X, Fiedler TL, Srinivasan S, Astete SG, Fredricks DN. Presence and Concentrations of Select Bacterial Vaginosis-Associated Bacteria Are Associated With Increased Risk of Pelvic Inflammatory Disease. Sex Transm Dis. 2020;47(5):344-6. Epub 2020/03/10. doi: 10.1097/olq.0000000000001164. PubMed PMID: 32149953; PMCID: PMC7167351.
  11. Mura M, Chaudhury S, Farooq F, Duncan EH, Beck K, Bergmann-Leitner ES. Optimized flow cytometric protocol for the detection of functional subsets of low frequency antigen-specific CD4(+) and CD8(+) T cells. MethodsX. 2020;7:101005. Epub 2020/08/11. doi: 10.1016/j.mex.2020.101005. PubMed PMID: 32775228; PMCID: PMC7396823.
  12. Rose OM, Fredricks DN, Soge OO, Farooq F, Tang G, Ness R, Haggerty CL. Stability of Chlamydia trachomatis RNA after long-term biobank storage. Sex Transm Infect. 2019;95(7):551. Epub 2019/10/20. doi: 10.1136/sextrans-2019-054141. PubMed PMID: 31628264.
  13. Farooq F, Beck K, Paolino KM, Phillips R, Waters NC, Regules JA, Bergmann-Leitner ES. Circulating follicular T helper cells and cytokine profile in humans following vaccination with the rVSV-ZEBOV Ebola vaccine. Sci Rep. 2016;6:27944. Epub 2016/06/22. doi: 10.1038/srep27944. PubMed PMID: 27323685; PMCID: PMC4914957.
  14. Sedegah M, Peters B, Hollingdale MR, Ganeshan HD, Huang J, Farooq F, Belmonte MN, Belmonte AD, Limbach KJ, Diggs C, Soisson L, Chuang I, Villasante ED. Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes. PLoS One. 2016;11(10):e0163026. Epub 2016/10/04. doi: 10.1371/journal.pone.0163026. PubMed PMID: 27695088; PMCID: PMC5047630.
    Erratum: Sedegah M, Peters B, Hollingdale MR, Ganeshan HD, Huang J, Farooq F, Belmonte MN, Belmonte AD, Limbach KJ, Diggs C, Soisson L, Chuang I, Villasante ED. Correction: Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes. PLoS One. 2016;11(12):e0168952. Epub 2016/12/21. doi: 10.1371/journal.pone.0168952. PubMed PMID: 27997615; PMCID: PMC5173278.
  15. Sedegah M, Hollingdale MR, Farooq F, Ganeshan H, Belmonte M, Huang J, Abot E, Limbach K, Chuang I, Tamminga C, Epstein JE, Villasante E. Controlled Human Malaria Infection (CHMI) differentially affects cell- mediated and antibody responses to CSP and AMA1 induced by adenovirus vaccines with and without DNA-priming. Hum Vaccin Immunother. 2015;11(11):2705-15. Epub 2015/08/21. doi: 10.1080/21645515.2015.1019186. PubMed PMID: 26292027; PMCID: PMC4685686.
  16. Sedegah M, Hollingdale MR, Farooq F, Ganeshan H, Belmonte M, Kim Y, Peters B, Sette A, Huang J, McGrath S, Abot E, Limbach K, Shi M, Soisson L, Diggs C, Chuang I, Tamminga C, Epstein JE, Villasante E, Richie TL. Sterile immunity to malaria after DNA prime/adenovirus boost immunization is associated with effector memory CD8+T cells targeting AMA1 class I epitopes. PLoS One. 2014;9(9):e106241. Epub 2014/09/12. doi: 10.1371/journal.pone.0106241. PubMed PMID: 25211344; PMCID: PMC4161338.
  17. Tamminga C, Sedegah M, Maiolatesi S, Fedders C, Reyes S, Reyes A, Vasquez C, Alcorta Y, Chuang I, Spring M, Kavanaugh M, Ganeshan H, Huang J, Belmonte M, Abot E, Belmonte A, Banania J, Farooq F, Murphy J, Komisar J, Richie NO, Bennett J, Limbach K, Patterson NB, Bruder JT, Shi M, Miller E, Dutta S, Diggs C, Soisson LA, Hollingdale MR, Epstein JE, Richie TL. Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection. Hum Vaccin Immunother. 2013;9(10):2165-77. Epub 2013/08/01. doi: 10.4161/hv.24941. PubMed PMID: 23899517; PMCID: PMC3906401.
  18. Sedegah M, Kim Y, Ganeshan H, Huang J, Belmonte M, Abot E, Banania JG, Farooq F, McGrath S, Peters B, Sette A, Soisson L, Diggs C, Doolan DL, Tamminga C, Villasante E, Hollingdale MR, Richie TL. Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP). Malar J. 2013;12:185. Epub 2013/06/07. doi: 10.1186/1475-2875-12-185. PubMed PMID: 23738590; PMCID: PMC3683343.
  19. Chuang I, Sedegah M, Cicatelli S, Spring M, Polhemus M, Tamminga C, Patterson N, Guerrero M, Bennett JW, McGrath S, Ganeshan H, Belmonte M, Farooq F, Abot E, Banania JG, Huang J, Newcomer R, Rein L, Litilit D, Richie NO, Wood C, Murphy J, Sauerwein R, Hermsen CC, McCoy AJ, Kamau E, Cummings J, Komisar J, Sutamihardja A, Shi M, Epstein JE, Maiolatesi S, Tosh D, Limbach K, Angov E, Bergmann-Leitner E, Bruder JT, Doolan DL, King CR, Carucci D, Dutta S, Soisson L, Diggs C, Hollingdale MR, Ockenhouse CF, Richie TL. DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity. PLoS One. 2013;8(2):e55571. Epub 2013/03/05. doi: 10.1371/journal.pone.0055571. PubMed PMID: 23457473; PMCID: PMC3573028.
  20. Sedegah M, Tamminga C, McGrath S, House B, Ganeshan H, Lejano J, Abot E, Banania GJ, Sayo R, Farooq F, Belmonte M, Manohar N, Richie NO, Wood C, Long CA, Regis D, Williams FT, Shi M, Chuang I, Spring M, Epstein JE, Mendoza-Silveiras J, Limbach K, Patterson NB, Bruder JT, Doolan DL, King CR, Soisson L, Diggs C, Carucci D, Dutta S, Hollingdale MR, Ockenhouse CF, Richie TL. Adenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: safety and immunogenicity in seronegative adults. PLoS One. 2011;6(10):e24586. Epub 2011/10/18. doi: 10.1371/journal.pone.0024586. PubMed PMID: 22003383; PMCID: PMC3189181.
  21. Tamminga C, Sedegah M, Regis D, Chuang I, Epstein JE, Spring M, Mendoza-Silveiras J, McGrath S, Maiolatesi S, Reyes S, Steinbeiss V, Fedders C, Smith K, House B, Ganeshan H, Lejano J, Abot E, Banania GJ, Sayo R, Farooq F, Belmonte M, Murphy J, Komisar J, Williams J, Shi M, Brambilla D, Manohar N, Richie NO, Wood C, Limbach K, Patterson NB, Bruder JT, Doolan DL, King CR, Diggs C, Soisson L, Carucci D, Levine G, Dutta S, Hollingdale MR, Ockenhouse CF, Richie TL. Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component. PLoS One. 2011;6(10):e25868. Epub 2011/10/18. doi: 10.1371/journal.pone.0025868. PubMed PMID: 22003411; PMCID: PMC3189219.
  22. Sedegah M, Kim Y, Peters B, McGrath S, Ganeshan H, Lejano J, Abot E, Banania G, Belmonte M, Sayo R, Farooq F, Doolan DL, Regis D, Tamminga C, Chuang I, Bruder JT, King CR, Ockenhouse CF, Faber B, Remarque E, Hollingdale MR, Richie TL, Sette A. Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein. Malar J. 2010;9:241. Epub 2010/08/26. doi: 10.1186/1475-2875-9-241. PubMed PMID: 20735847; PMCID: PMC2939619.